Key regions: China, South Korea, Canada, India, France
The Analgesics (Pharmacies) market in Central Africa has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to the development of this market. Customer preferences in Central Africa have played a crucial role in the growth of the Analgesics (Pharmacies) market. Customers in this region have shown a preference for over-the-counter pain relief medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen. This preference can be attributed to the ease of access and affordability of these medications. Customers also value the convenience of purchasing analgesics from local pharmacies, as they can easily obtain them without a prescription. Several trends in the market have further fueled its growth. One key trend is the increasing awareness and understanding of the benefits of analgesics in managing pain. As education and healthcare infrastructure improve in Central Africa, more people are becoming aware of the availability and effectiveness of analgesics. This has led to an increase in demand for these medications. Another trend is the expansion of pharmacy chains in the region. As the healthcare sector develops, more pharmacies are being established, providing easier access to analgesics for customers. This expansion has also led to increased competition among pharmacies, resulting in lower prices and a wider range of products available to customers. Local special circumstances in Central Africa have also contributed to the growth of the Analgesics (Pharmacies) market. The region has a high prevalence of infectious diseases, such as malaria and HIV/AIDS, which can cause various types of pain. As a result, there is a constant demand for analgesics to manage the pain associated with these diseases. Additionally, the region's population is growing, leading to an increased need for healthcare services and medications. Underlying macroeconomic factors have also played a role in the development of the Analgesics (Pharmacies) market in Central Africa. Economic growth in the region has resulted in increased disposable income, allowing more people to afford analgesics. Additionally, improvements in healthcare infrastructure and access to healthcare services have contributed to the growth of the market. In conclusion, the Analgesics (Pharmacies) market in Central Africa is developing due to customer preferences for over-the-counter pain relief medications, increasing awareness of the benefits of analgesics, the expansion of pharmacy chains, local special circumstances, and underlying macroeconomic factors. As the region continues to develop, it is expected that the market will continue to grow in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
